Quoin pharmaceuticals announces fourth quarter and 2023 financial results and corporate update conference call to be held on thursday march 14th at 8:30 am et

Ashburn, va., march 07, 2024 (globe newswire) -- quoin pharmaceuticals ltd. (nasdaq: qnrx) (the “company” or “quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the company plans to release its fourth quarter and 2023 financial results after the market closes on wednesday, march 13, 2024.
QNRX Ratings Summary
QNRX Quant Ranking